Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Cholestatic Pruritus Market Size?

There has been a robust expansion of the cholestatic pruritus market size in the past few years. The market size is projected to escalate from $19.2 billion in 2024 to $20.22 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors such as an increasing number of skin disorder cases, higher research and development investments, demand for efficacious treatments, heightened awareness about the condition, and supportive regulatory frameworks have contributed to the growth during the historic period.

The market size for cholestatic pruritus is set to experience significant growth, reaching $24.78 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. This growth over the forecast period is primarily due to factors such as an aging population, rising cases of conditions like atopic dermatitis and urticaria, increased prevalence of chronic kidney diseases, and an increase in conditions related to pruritus. Key developments predicted for this period include the emergence of new therapy options, collaborations with leading businesses for cholestasis pruritus research, improvements in treatment modalities, enhancement of healthcare facilities, and technological advancements.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp

Which Factors Are Steering Growth In The Cholestatic Pruritus Market?

The growth of the cholestatic pruritus market is anticipated to be fuelled by the rising incidence of liver diseases. These broad spectrum conditions adversely impact liver function, arising from infections, autoimmune disorders, damage from toxins, and genetic diseases, potentially leading to inflammation, scarring, or even liver failure. The heightened occurrence of liver diseases can largely be attributed to escalating rates of obesity, diabetes, alcohol consumption, viral hepatitis infections, and exposure to environmental hazards and toxins. Cholestatic pruritus plays a crucial role in recognizing and managing liver diseases, acting as a significant symptom that points towards hampered bile flow. This often necessitates more detailed examinations and interventions for potential liver disorders. To illustrate, in July 2023, the Office for Health Improvement and Disparities, a UK-based governmental agency dedicated to addressing health disparities, reported that hospital admissions for liver disease in England escalated by 22% in the year ending 2022, jumping from 67,458 to 82,290. Thus, the escalating incidence of liver diseases is likely to boost the growth of the cholestatic pruritus market.

How Is The Cholestatic Pruritus Market Organized By Different Segments?

The cholestatic pruritusmarket covered in this report is segmented –

1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types

2) By Treatment Type: Medications; Phototherapy; Other Treatment Types

3) By Route Of Administration: Oral; Topical; Injectable

4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders

What Current And Upcoming Trends Are Shaping The Cholestatic Pruritus Market?

Leading enterprises in the cholestatic pruritus market are concentrating on the creation of novel solutions, for instance, oral remedies. These are intended to handle symptoms more effectively, boost patient adherence, and deliver targeted relief by tackling the root causes of bile salt buildup and inflammation. A medicinal liquid formulation, the oral solution for cholestatic pruritus is devised to decrease bile acid accumulation and soothe extreme itching in cholestasis patients. For example, Mirum Pharmaceuticals Inc., a biopharmaceutical firm based in the U.S, obtained U.S. Food and Drug Administration (FDA) approval for LIVMARLI (maralixibat) oral solution, made to treat cholestatic pruritus in patients over the age of five suffering from progressive familial intrahepatic cholestasis (PFIC) in March 2024. PFIC type 2 has been declared a breakthrough therapy, administered once a day orally by this ileal bile acid transporter inhibitor. LIVMARLI is set to significantly affect cholestatic pruritus patients linked to PFIC, bringing forth a highly sought-after treatment for the rarest types.

Who Are The Most Influential Companies In The Cholestatic Pruritus Market?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Which Region Dominates The Cholestatic Pruritus Market Today?

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21140&type=smp

Browse Through More Reports Similar to the Global Cholestatic Pruritus Market 2025, By The Business Research Company

Pruritus Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

Pruritus Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Primary Biliary Cholangitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model